The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity
Open accessAbstract
The effects of acute and subchronic nicotine and (+)‐amphetamine on the extracellular levels of dopamine and its metabolites, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in nucleus accumbens (NAc) have been studied in conscious, freely‐moving rats by use of in vivo microdialysis. In rats which had been habituated to the test apparatus for approximately 80 min, the acute subcutaneous (s.c.) administration of nicotine (0.1 or 0.4 mg kg−1) caused a dose‐dependent increase (P < 0.01) in spontaneous activity and evoked significant increases (P < 0.05) in the extracellular levels of DOPAC and HVA. Measurements made 24 h after the last injection of nicotine showed that pretreatment with the higher doses tested (0.4 mg kg−1) resulted in increased basal levels of dopamine (P < 0.01) and decreased basal levels of DOPAC (P < 0.05) in the NAc dialysates. Pretreatment with nicotine (0.1 or 0.4 mg kg−1 daily for 5 days) enhanced the effects of the drug on spontaneous locomotor activity and enhanced the effects of the drug on extracellular levels of dopamine to the extent that the response became significant (P < 0.05). If a dopamine uptake inhibitor, nomifensine, was added to the Ringer solution used to dialyse the probe, the s.c. administration of both acute and subchronic nicotine (0.4 mg kg−1) resulted in significant increases (P < 0.05) in the dopamine concentration in the dialysate. Under these conditions, pretreatment with nicotine prior to the test day prolonged (P < 0.05) the dopamine response to a challenge dose of nicotine. Subcutaneous injections of (+)‐amphetamine (0.2 or 0.5 mg kg−1) evoked dose‐dependent increases in both spontaneous activity and the concentration of dopamine in NAc dialysates. These responses were unaffected by 5 days pretreatment with the drug. The results of this study support the conclusion that the enhanced locomotor response to nicotine observed in animals pretreated with the drug prior to the test day is associated with potentiation of its effects on dopamine secretion in the NAc.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Nicotine-mediated neurotransmitter release can occur after acute nicotine exposure that activates nAChRs and after chronic nicotine exposure that desensitizes nAChRs.
“For instance, nicotine-mediated neurotransmitter release can occur after acute nicotine exposure that activates nAChRs and after chronic nicotine exposure that desensitizes nAChRs (Benwell and Balfour, 1992; Iyaniwura et al., 2001).”
From It is not “either/or”: Activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood (2008) · cites this paper as Benwell and Balfour, 1992
The Results and Discussion (pages not available in our copy) report increased nucleus accumbens dopamine after repeated nicotine treatment and infer dopamine release after acute treatment, although the acute increase in extracellular dopamine was not statistically significant without an uptake inhibitor. They do not establish that acute exposure activates nAChRs or that chronic exposure desensitizes them; those receptor mechanisms are not supported by this paper. (LLM, conf=0.86)
Experimental — accuracy not yet measuredRepeated nicotine administration leads to increased release of dopamine that persists and shows a sensitized response despite nAChR desensitization.
“As mentioned earlier, repeated nicotine administration leads to increased release of dopamine that persists, and indeed shows a sensitized response (increased dopamine (DA) release in response to challenge with the same nicotine dose), despite any nAChR desensitization that is likely to have occurred (Benwell and Balfour, 1992; Iyaniwura et al., 2001).”
From It is not “either/or”: Activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood (2008) · cites this paper as Benwell and Balfour, 1992
The Results (‘The effect of acute and subchronic nicotine’; page unavailable) report elevated basal nucleus accumbens dopamine 27 hours after the last nicotine injection, and the Discussion reports an enhanced dopamine response to a nicotine challenge after pretreatment. The Discussion concludes that the dopamine system may become sensitized. Our copy does not establish that nAChRs had desensitized, so the ‘despite desensitization’ part is unsupported by this paper. (LLM, conf=0.85)
Experimental — accuracy not yet measuredBoth nicotine and cotinine have been shown to facilitate dopamine release.
“both nicotine59 and cotinine60 have been shown to facilitate dopamine release”
From β2-Nicotinic Acetylcholine Receptor Availability During Acute and Prolonged Abstinence From Tobacco Smoking (2009) · cites this paper as [59]
Prolonged partial occupancy of the receptor by nicotine or cotinine may contribute to the feelings of craving reported 2 h after the last cigarette and throughout the first week of abstinence.
“Dopamine release has been associated with the feeling of craving58, and both nicotine59 and cotinine60 have been shown to facilitate dopamine release, thus the prolonged partial occupancy of the receptor by nicotine or cotinine, may contribute to the feelings of craving that are reported 2 h after the last cigarette and throughout the first week of abstinence.”
From β2-Nicotinic Acetylcholine Receptor Availability During Acute and Prolonged Abstinence From Tobacco Smoking (2009) · cites this paper as [59]
Sensitization caused by repeated drug use has been observed with many drugs of abuse, including alcohol and nicotine.
“Sensitization caused by repeated drug use has been observed with many drugs of abuse, including alcohol and nicotine (Benwell & Balfour, 1992; Cadoni & Di Chiara, 2000; Govind, Vezina, & Green, 2009; Laviolette & van der Kooy, 2004).”
From Cued for Risk: Evidence for an Incentive Sensitization Framework to Explain the Interplay between Stress and Anxiety, Substance Abuse, and Reward Uncertainty in Disordered Gambling Behavior (2019) · cites this paper as Benwell & Balfour, 1992
For nicotine, animal studies have shown that repeated intermittent injections of nicotine typically cause sensitization or enhancement of the drug's locomotor activating effects.
“For nicotine, animal studies have shown that repeated intermittent injections of nicotine typically cause sensitization or enhancement of the drug’s locomotor activating effects (L. K. Baker et al., 2013; Benwell & Balfour, 1992; Clarke & Kumar, 1983; Vezina, McGehee, & Green, 2007).”
From Cued for Risk: Evidence for an Incentive Sensitization Framework to Explain the Interplay between Stress and Anxiety, Substance Abuse, and Reward Uncertainty in Disordered Gambling Behavior (2019) · cites this paper as Benwell & Balfour, 1992
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,959 · see citing works
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733 · see citing works
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747 · see citing works
Kelly, P. H., Seviour, P. W., & Iversen, S. D. (1975) · Brain Research · doi:10.1016/0006-8993(75)90233-4 · Cited by 1,740 · see citing works
Ho¨kfelt, T., Skirboll, L. R., Rehfeld, J. F., Goldstein, M., MARKEY, K., & Dann, O. (1980) · Neuroscience · doi:10.1016/0306-4522(80)90127-x · Cited by 713 · see citing works
Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats
Imperato, A., Mulas, A., & Di Chiara, G. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90629-1 · Cited by 693 · see citing works
The pharmacological and anatomical substrates of the amphetamine response in the rat
Creese, I., & Iversen, S. D. (1975) · Brain Research · doi:10.1016/0006-8993(75)90834-3 · Cited by 583 · see citing works
Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens
Kalivas, P. W., & Duffy, P. (1990) · Synapse · doi:10.1002/syn.890050104 · Cited by 544 · see citing works
Benveniste, H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07243.x · Cited by 524 · see citing works
Robinson, T. E., & Whishaw, I. Q. (1988) · Brain Research · doi:10.1016/0006-8993(88)91560-0 · Cited by 520 · see citing works
Lyness, W. H., Friedle, N. M., & Moore, K. E. (1979) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(79)90040-6 · Cited by 457 · see citing works
The effects of nicotine on locomotor activity in non‐tolerant and tolerant rats
Clarke, P. B. S., & Kumar, R. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb09398.x · Cited by 457 · see citing works
Persistent Behavior at High Rates Maintained by Intravenous Self-Administration of Nicotine
Goldberg, S. R., Spealman, R. D., & Goldberg, D. M. (1981) · Science · doi:10.1126/science.7291998 · Cited by 343 · see citing works
Clarke, P. B., Fu, D. S., Jakubovic, A., & Fibiger, H. C. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22152-8 · Cited by 318 · see citing works
Selective dopamine antagonists reduce nicotine self-administration
Corrigall, W. A., & Coen, K. M. (1991) · Psychopharmacology · doi:10.1007/bf02244174 · Cited by 276 · see citing works
Acute and chronic tolerance to nicotine measured by activity in rats
Stolerman, I. P., Fink, R. S., & Jarvik, M. E. (1973) · Psychopharmacology · doi:10.1007/bf00429192 · Cited by 247 · see citing works
Prediction of abuse liability of drugs using IV self-administration by rats
Collins, R. J., Weeks, J. R., Cooper, M. M., Good, P. I., & Russell, R. R. (1983) · Psychopharmacology · doi:10.1007/bf00426372 · Cited by 236 · see citing works
Fallon, J. H., & Moore, R. Y. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901800309 · Cited by 226 · see citing works
Effect of dose on cocaine self-administration behavior and dopamine levels in the nucleus accumbens
Pettit, H. O., & Justice, J. B. (1991) · Brain Research · doi:10.1016/0006-8993(91)90690-w · Cited by 225 · see citing works
Westerink, B. H. C., & Vries, J. B. D. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb01798.x · Cited by 187 · see citing works
In-vivo brain dialysis of neurotransmitters
Chiara, G. D. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90197-g · Cited by 183 · see citing works
Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens
Damsma, G., Day, J. C., & Fibiger, H. C. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90798-x · Cited by 169 · see citing works
Locomotor activity in rats after administration of nicotinic agonists intracerebrally
Reavill, C. A., & Stolerman, I. P. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb14693.x · Cited by 158 · see citing works
Nicotine self‐administration in rats
Cox, B. M., D, A. G. M., & Nelson, W. T. (1984) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1984.tb10118.x · Cited by 83 · see citing works
Andersson, K., Fuxé, K., & Agnati, L. F. (1981) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1981.tb06827.x · Cited by 80 · see citing works
Singer, G., Wallace, M., & Hall, R. (1982) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(82)90321-5 · Cited by 79 · see citing works
Izenwasser, S., Jacocks, H. M., Rosenberger, J. G., & Cox, B. M. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08192.x · Cited by 72 · see citing works
Drug Self-Administration: An Analysis of the Reinforcing Effects of Drugs
Pickens, R. W., Meisch, R. A., & Thompson, T. I. (1978) · Springer eBooks · doi:10.1007/978-1-4684-3186-5_1 · Cited by 71 · see citing works
Schenk, S., Snow, S., & Horger, B. A. (1991) · Psychopharmacology · doi:10.1007/bf02244075 · Cited by 68 · see citing works
Receptor mechanisms of nicotine-induced locomotor hyperactivity in chronic nicotine-treated rats
Fung, Y. K., & Lau, Y. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90721-2 · Cited by 65 · see citing works
Fuxé, K., Andersson, K., H�rfstrand, A., et al. (1986) · Journal of Neural Transmission · doi:10.1007/bf01243356 · Cited by 51 · see citing works
Dopamine-like action of nicotine: lack of tolerance and reverse tolerance
Lapin, E. P., Maker, H. S., Sershen, H. W., et al. (1987) · Brain Research · doi:10.1016/0006-8993(87)91114-0 · Cited by 48 · see citing works
Andersson, K., Fuxé, K., Lf, A., et al. (1981) · PubMed · Cited by 43 · see citing works
Fung, Y. K. (1989) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1989.tb06334.x · Cited by 35 · see citing works
Aversive environmental stimuli as a factor in the psychostimulant response to nicotine
Vale, A. L., & Balfour, D. J. K. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90048-8 · Cited by 19 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Balfour, D.J.K. pp. 453-481. London, Oxford: Pergamon press.
- Iversen, L.L., Iversen, S.D. & Snyder, S.H. Vol. 12, pp. 1-37. New York: Plenum.
Cited by
Sorted by citations
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346 · see citing works
Guidelines on nicotine dose selection for in vivo research
Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0441-0 · Cited by 824 · see citing works
Self-citationPICCIOTTO, M., ADDY, N., MINEUR, Y., & BRUNZELL, D. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.12.005 · Cited by 451 · see citing works
Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal
S. Watkins, G. F. K. (2000) · Nicotine & Tobacco Research · doi:10.1080/14622200050011277 · Cited by 424 · see citing works
Nicotinic receptors in the brain. Links between molecular biology and behavior
Picciotto, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00146-3 · Cited by 354 · see citing works
Govind, A. P., Vezina, P., & Green, W. N. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.011 · Cited by 338 · see citing works
Neurobiology of the nicotine withdrawal syndrome
Kenny, P. J., & Markou, A. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00651-7 · Cited by 310 · see citing works
Steketee, J. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00233-3 · Cited by 293 · see citing works
Nicotine: from molecular mechanisms to behaviour
Wonnacott, S., Sidhpura, N., & Balfour, D. J. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.12.002 · Cited by 263 · see citing works
Self-citationNicotine-induced conditioned place preference in adolescent and adult rats
Vastola, B. J., Douglas, L. A., Varlinskaya, E. I., & Spear, L. P. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00818-1 · Cited by 251 · see citing works
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum
Grady, S. R., Salminen, O., Laverty, D. C., Whiteaker, P., McIntosh, J. M., Collins, A. C., & Marks, M. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.032 · Cited by 252 · see citing works
Grottick, A. J., & Higgins, G. A. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00305-3 · Cited by 240 · see citing works
The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence
Balfour, D. J. K., Wright, A. E., Benwell, M. E. M., & Birrell, C. E. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00202-3 · Cited by 231 · see citing works
Differential changes in accumbens shell and core dopamine in behavioral sensitization to nicotine
Cadoni, C., & Di Chiara, G. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00843-2 · Cited by 180 · see citing works
Benwell, M. E. M., Balfour, D. J. K., & Birrell, C. E. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb13248.x · Cited by 169 · see citing works
Self-citationCosgrove, K. P., Batis, J., Bois, F., Maciejewski, P. K., Esterlis, I., Kloczynski, T., Stiklus, S., Krishnan-Sarin, S., O’Malley, S., Perry, E., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.41 · Cited by 159 · see citing works
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148 · see citing works
Nicotinic–serotonergic interactions in brain and behaviour
Seth, P., Cheeta, S., Tucci, S., & File, S. E. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00715-8 · Cited by 145 · see citing works
The Role of α6-Containing Nicotinic Acetylcholine Receptors in Nicotine Reward and Withdrawal
Jackson, K. J., McIntosh, J. M., Brunzell, D. H., Sanjakdar, S. S., & Damaj, M. I. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155457 · Cited by 135 · see citing works
Court, J. A., Lloyd, S., Thomas, N., Piggott, M. A., Marshall, E. F., Morris, C. M., Lamb, H., Perry, R. H., Johnson, M., & Perry, E. K. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00088-8 · Cited by 135 · see citing works
Ferrari, R., Le Novère, N., Picciotto, M. R., Changeux, J. P., & Zoli, M. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2001.02009.x · Cited by 132 · see citing works
Fowler, C. D., Arends, M. A., & Kenny, P. J. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c360e · Cited by 131 · see citing works
Rahman, S., Zhang, J., Engleman, E. A., & Corrigall, W. A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.010 · Cited by 110 · see citing works
Gao, M., Jin, Y., Yang, K., Zhang, D., Lukas, R. J., & Wu, J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1943-10.2010 · Cited by 99 · see citing works
The Neuronal Pathways Mediating the Behavioral and Addictive Properties of Nicotine
Balfour, D. J. K. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-69248-5_8 · Cited by 99 · see citing works
Self-citationAdriani, W., Deroche-Gamonet, V., Le Moal, M., Laviola, G., & Piazza, P. V. V. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0125-1 · Cited by 86 · see citing works
Phencyclidine exacerbates attentional deficits in a neurodevelopmental rat model of schizophrenia
Le Pen, G., Grottick, A. J., Higgins, G. A., & Moreau, J.-L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300208 · Cited by 82 · see citing works
Brunzell, D. H., Chang, J. R., Schneider, B., Olausson, P., Taylor, J. R., & Picciotto, M. R. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0099-z · Cited by 71 · see citing works
Venugopalan, V. V., Casey, K. F., O'Hara, C., O'Loughlin, J., Benkelfat, C., Fellows, L. K., & Leyton, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.135 · Cited by 70 · see citing works
Topiramate selectively attenuates nicotine-induced increases in monoamine release
Schiffer, W. K., Gerasimov, M. R., Marsteller, D. A., Geiger, J., Barnett, C., Alexoff, D. L., & Dewey, S. L. (2001) · Synapse · doi:10.1002/syn.10000 · Cited by 69 · see citing works
Hellberg, S. N., Russell, T. I., & Robinson, M. J. F. (2019) · Cognitive, Affective, & Behavioral Neuroscience · doi:10.3758/s13415-018-00662-3 · Cited by 65 · see citing works
“For nicotine, animal studies have shown that repeated intermittent injections of nicotine typically cause sensitization or enhancement of the drug’s locomotor activating effects (L. K. Baker et al., 2013; Benwell & Balfour, 1992; Clarke & Kumar, 1983; Vezina, McGehee, & Green, 2007).”
Neurochemical alterations produced by daily nicotine exposure in periadolescent vs. adult male rats
Collins, S. L., Wade, D., Ledon, J., & Izenwasser, S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.08.039 · Cited by 62 · see citing works
Iyaniwura, T., Wright, A., & Balfour, D. (2001) · Psychopharmacology · doi:10.1007/s002130100852 · Cited by 57 · see citing works
Self-citationChronic nicotine administration in the drinking water affects the striatal dopamine in mice
Pietilä, K., & Ahtee, L. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00235-5 · Cited by 50 · see citing works
Ostafin, B. D., Marlatt, G. A., & Troop-Gordon, W. (2010) · Psychology of Addictive Behaviors · doi:10.1037/a0017897 · Cited by 45 · see citing works
Nicotine-conditioned locomotor sensitization in rats: assessment of the US-preexposure effect
Bevins, R. A., & Palmatier, M. I. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00009-3 · Cited by 42 · see citing works
Palmatier, M. I., Levin, M. E., Mays, K. L., Donny, E. C., Caggiula, A. R., & Sved, A. F. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1666-5 · Cited by 40 · see citing works
Ericson, M., Olausson, P., Engel, J. A., & Söderpalm, B. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00191-6 · Cited by 26 · see citing works
Munafó, M. R., Mannie, Z. N., Cowen, P. J., Harmer, C. J., & McTavish, S. B. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107077216 · Cited by 25 · see citing works
Saito, M., O’Brien, D., Kovacs, K. M., Wang, R., Zavadil, J., & Vadasz, C. (2005) · Neurochemical Research · doi:10.1007/s11064-005-7047-5 · Cited by 14 · see citing works
Neugebauer, N. M., Cortright, J. J., Sampedro, G. R., & Vezina, P. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.11.035 · Cited by 12 · see citing works
The cessation and detoxification effect of tea filters on cigarette smoke
Yan, J., Di, X., Liu, C., Zhang, H., Huang, X., Zhang, J., Zhao, Y., Zhang, L., Chang, Y., Liang, Y., et al. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-0097-1 · Cited by 10 · see citing works
- Authors
- Benwell, M. E. M., & Balfour, D. J. K.
- Affiliations
- University of Dundee (GB)
- ORCID
- Balfour, David J.K.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1992-04
- Volume
- 105
- Issue
- 4
- Pages
- 849-856
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1908718
- OpenAlex
- W1999762185
- Cited by
- 426
- References
- 36
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 6 · 2022: 4 · 2021: 8 · 2020: 5 · 2019: 6 · 2018: 7 · 2017: 3 · 2016: 11 · 2015: 14 · 2014: 8 · 2013: 17 · 2012: 13
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Keywords
- nicotine, nucleus accumbens, dopamine, locomotor activity, amphetamine, DOPAC, homovanillic acid, dopamine uptake inhibition, nomifensine, dopamine release, extracellular dopamine, rats, in vivo microdialysis, sensitization
- MeSH terms
- Animals, Dextroamphetamine, Dopamine, Homovanillic Acid, Male, Motor Activity, Nicotine, Nomifensine, Nucleus Accumbens, Rats, Inbred Strains, 3,4-Dihydroxyphenylacetic Acid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review